Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute pulmonary embolism

P D Stein1

  • 1Case Western Reserve University, Cleveland, Ohio.

Disease-A-Month : DM
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Preventing deep venous thrombosis (DVT) is key to avoiding pulmonary embolism (PE). Various methods like heparin and compression stockings are used, with optimal prophylaxis tailored to individual patient risk factors and conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism.

Thrombosis and haemostasis·2013
Same author

Effect of compression stockings on venous blood velocity and blood flow.

Thrombosis and haemostasis·2010
Same author

Noninvasive imaging of the coronary arteries.

Minerva cardioangiologica·2006
Same author

Clinical validity of a normal pulmonary angiogram in patients with suspected pulmonary embolism--a critical review.

Clinical radiology·2002
Same author

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Annals of internal medicine·2001
Same author

Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.

Journal of medicinal chemistry·2001
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pulmonary Medicine

Background:

  • Deep venous thrombosis (DVT) is a common complication following surgical procedures, with varying incidence and prevention effectiveness.
  • Pulmonary embolism (PE) prevention is critically dependent on effective DVT prophylaxis.
  • Several methods exist for DVT prevention, including anticoagulants and mechanical devices.

Purpose of the Study:

  • To review current strategies for the prevention of deep venous thrombosis (DVT) and pulmonary embolism (PE).
  • To discuss the role and effectiveness of various prophylactic measures.
  • To highlight diagnostic approaches for PE based on clinical presentation.

Main Methods:

  • Review of established and emerging methods for DVT prophylaxis.

Related Experiment Videos

  • Discussion of anticoagulant therapies (heparin, warfarin) and mechanical methods (compression stockings, pneumatic compression).
  • Analysis of clinical manifestations and bedside diagnostic clues for PE.

    • Main Results:

    • Low-dose heparin, low molecular weight heparin, compression stockings, and pneumatic compression are effective in DVT prevention.
    • Warfarin's optimal dosing and monitoring have evolved with the introduction of the International Normalized Ratio (INR).
    • Clinical presentation of PE often includes dyspnea, tachypnea, or pleuritic pain, with specific syndromes like pulmonary hemorrhage-infarction being common.

    Conclusions:

    • The choice of DVT prophylaxis should be individualized based on patient risk and specific clinical circumstances.
    • Heparin remains a primary anticoagulant for DVT prevention, with low-dose regimens associated with rare major bleeding.
    • Bedside diagnosis of PE is crucial for guiding further diagnostic testing and management.